|Brand name(s), other common name(s)||Kepivance®|
|Drug type||Growth factor|
|How the drug is given||Intravenously (IV)|
Palifermin is FDA approved to help prevent or lessen severe oral mucositis (inflammation of the mucous membrane of the mouth) in patients receiving certain types of blood cancer therapy.
Side effects needing medical attention:Check with your doctor immediately if you develop a rash.